MedPath
HSA Approval

SUPRIM SUSPENSION

SIN01417P

SUPRIM SUSPENSION

SUPRIM SUSPENSION

May 20, 1988

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

J01EE01

sulfamethoxazole and trimethoprim

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

TRIMETHOPRIM

40 mg/5 ml

Trimethoprim

SULPHAMETHOXAZOLE

200 mg/5 ml

Sulfamethoxazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUPRIM SUSPENSION - HSA Approval | MedPath